[Community acquired pneumonia - treatment options according to the international recommendations]

Wiad Lek. 2016;69(2 Pt 1):139-44.
[Article in Polish]

Abstract

Pneumonia remains one of the main reasons of heath care system utilization. Quick diagnosis and prompt treatment initiation determine favorable outcome. Empirical antibiotic treatment allows to achieve treatment success in most patients. Treatment recommendations are based on big epidemiological trials. Nevertheless, it is sometimes necessary to know the definite etiologic factor of pneumonia. In these cases microbiological diagnostics is useful, i.e. sputum microscopy and culture, blood culture, bronchial lavage culture, bacterial antigen tests in urine, molecular tests. Serological tests do not help much in everyday clinical practice. The most common microorganisms causing community acquired pneumonia (CAP) are: Streptococcus pneumoniae, atypical bacteria (Mycoplasma pneumoniae, Chlamydophila pneumoniae, Legionella pneumophila), Haemophilus influenzae, influenza virus. Staphylococcus aureus and Pseudomonas aeruginosa rarely are etiologic factors of CAP. First line antibiotics in pneumonia treatment are beta - lactams. In case of allergy or intolerance of beta - lactams, new fluorochinolones should be used. Macrolides are useful if the atypical etiology is suspected. Duration of treatment in most cases should not exceed 7 days, sometimes it may be even shorter.

Keywords: empirical treatment; etiology; pneumonia.

Publication types

  • English Abstract

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Community-Acquired Infections / diagnosis*
  • Community-Acquired Infections / drug therapy*
  • Drug Therapy / standards*
  • Humans
  • Pneumonia, Bacterial / diagnosis*
  • Pneumonia, Bacterial / drug therapy*
  • Practice Guidelines as Topic*

Substances

  • Anti-Bacterial Agents